 |
市場調査レポート
商品コード
980485
ドライパウダー吸入器市場：洞察、競合情勢および2025年までの予測Dry Powder Inhaler Devices Market Insights, Competitive Landscape and Market Forecast-2025 |
||||||
| ドライパウダー吸入器市場：洞察、競合情勢および2025年までの予測 |
|
出版日: 受注生産
発行: DelveInsight Business Research LLP
ページ情報: 英文 120 Pages
納期: 約10営業日
|
ドライパウダー吸入器は、肺に効率的に薬を投与するために使用される医療機器であり、呼吸器疾患のある患者は、コンパクトで持ち運びが簡単なドライパウダー吸入器を使用しています。喘息、肺疾患の発生率の増加、および有毒化学物質の大量排出による汚染の増加により、ドライパウダー吸入器（DPI）の需要が増加しています。ただし、湿気による特性の損失、電動ポンプやネブライザーなどの他の競合製品の存在は、市場の成長を妨げています。
当レポートは、世界主要7ヶ国（米国、欧州5ヶ国（ドイツ、スペイン、フランス、イタリア、英国）および日本）のドライパウダー吸入器市場について調査しており、市場規模および予測、成長要因および障壁、製品プロファイル、KOLの見解、競合情勢、主要企業のプロファイルなどの情報を提供しています。
当レポート掲載の企業リスト：
Cipla Inc., GlaxoSmithKline Plc., Teicos Pharma Ltd., Presspart Manufacturing Ltd., Beximco Pharma Ltd., Catalent, Inc., Hovione FarmaCiencia SA., AstraZeneca Plc., Bespak Europe Ltd., Luckys Pharma, SRS Pharmaceuticals Pvt. Ltd.
DelveInsight's 'Dry Powder Inhaler Devices -Market Insights, Competitive Landscape and Market Forecast - 2025' report delivers an in-depth understanding of Dry Powder Inhaler Devices and the historical and forecasted Dry Powder Inhaler Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Dry Powder Inhaler Devices market report provides an overview of Dry Powder Inhaler Devices , reasons to get Dry Powder Inhaler Devices as well as its advantages and limitations. Additionally, the report provides insight on the Dry Powder Inhaler Devices market share of the individual Dry Powder Inhaler Devices devices, current and forecasted Dry Powder Inhaler Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Dry Powder Inhaler Devices Overview
The dry powder inhaler is a medical device that is used to administer medicine efficiently to the lungs. The drug comes in dry powder form. Patients with multiple respiratory disorders use dry powder inhalers because they are compact and simple to transport. Owing to increasing incidences of asthma, lung diseases, and increasing contamination due to the high discharge of toxic chemicals, the increasing demand for dry powder inhaler (DPI) devices may be mainly attributed. These instruments are not immune to moisture and thus, once the drug comes into contact with moisture, it loses its properties. Also, the presence of other competing goods on the market, such as electric pumps and nebulizers, are the reasons that limit the development of the market.
Study Period: 2017-2025
List of Companies:
Cipla Inc., GlaxoSmithKline Plc., Teicos Pharma Ltd., Presspart Manufacturing Ltd., Beximco Pharma Ltd., Catalent, Inc., Hovione FarmaCiencia SA., AstraZeneca Plc., Bespak Europe Ltd., Luckys Pharma, and SRS Pharmaceuticals Pvt. Ltd.
Dry Powder Inhaler Devices - Competitive Analysis
This segment of the report provides a brief competitive analysis of Dry Powder Inhaler Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.
Dry Powder Inhaler Devices : Market Analysis
This segment illustrates the market of Dry Powder Inhaler Devices across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
KOL- Views
To keep up with the market trends, we take KOLs and SME's opinion working in Dry Powder Inhaler Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Dry Powder Inhaler Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Market Insights:
Competitive Landscape:
4.2.1.Company Overview
Products detail in the report…
6.1.1. Dry Powder Inhaler Devices : Market Analysis in the 7MM by type (2017-2025)
6.1.2. Dry Powder Inhaler Devices : Market Analysis in the 7MM by application (2017-2025)
6.1.3. Dry Powder Inhaler Devices : Market Analysis in the 7MM by end user (2017-2025)
6.2.1. Dry Powder Inhaler Devices : Market Analysis in the US by type (2017-2025)
6.2.2. Dry Powder Inhaler Devices : Market Analysis in the US by application (2017-2025)
6.2.3. Dry Powder Inhaler Devices : Market Analysis in the US by end user (2017-2025)
6.3.1. Dry Powder Inhaler Devices : Market Analysis in Germany by type (2017-2025)
6.3.2. Dry Powder Inhaler Devices : Market Analysis in Germany by application (2017-2025)
6.3.3. Dry Powder Inhaler Devices : Market Analysis in Germany by end user (2017-2025)
6.3.1. Dry Powder Inhaler Devices : Market Analysis in France by type (2017-2025)
6.3.2. Dry Powder Inhaler Devices : Market Analysis in France by application (2017-2025)
6.3.3. Dry Powder Inhaler Devices : Market Analysis in France by end user (2017-2025)
6.5.1. Dry Powder Inhaler Devices : Market Analysis in Italy by type (2017-2025)
6.5.2. Dry Powder Inhaler Devices : Market Analysis in Italy by application (2017-2025)
6.5.3. Dry Powder Inhaler Devices : Market Analysis in Italy by end user (2017-2025)
6.6.1. Dry Powder Inhaler Devices : Market Analysis in Spain by type (2017-2025)
6.6.2. Dry Powder Inhaler Devices : Market Analysis in Spain by application (2017-2025)
6.6.3. Dry Powder Inhaler Devices : Market Analysis in Spain by end user (2017-2025)
6.7.1. Dry Powder Inhaler Devices : Market Analysis in the UK by type (2017-2025)
6.7.2. Dry Powder Inhaler Devices : Market Analysis in the UK by application (2017-2025)
6.7.3. Dry Powder Inhaler Devices : Market Analysis in the UK by end user (2017-2025)
6.8.1. Dry Powder Inhaler Devices : Market Analysis in Japan by type (2017-2025)
6.8.2. Dry Powder Inhaler Devices : Market Analysis in Japan by application (2017-2025)
6.8.3. Dry Powder Inhaler Devices : Market Analysis in Japan by end user (2017-2025)
比較リスト
